MADELAINE LONG: Open Payments
NPI 1942881669 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 20 payments from 8 companies in 2025. Trend: 2023 $310 · 2024 $328 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $434 |
| Otsuka America Pharmaceutical, Inc. | 2 | $139 |
| Janssen Pharmaceuticals, Inc | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $122 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| ABBVIE INC. | 2 | $36 |
| Lilly USA, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: Auvelity, REXULTI, SPRAVATO, CAPLYTA, Jornay PM, VRAYLAR, ZEPBOUND, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
